CollPlant Biotechnologies (XTAE:CLGN) Net Margin % : -1,568.10% (As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

What is CollPlant Biotechnologies Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. CollPlant Biotechnologies's Net Income for the three months ended in Dec. 2023 was ₪-17.16 Mil. CollPlant Biotechnologies's Revenue for the three months ended in Dec. 2023 was ₪1.09 Mil. Therefore, CollPlant Biotechnologies's net margin for the quarter that ended in Dec. 2023 was -1,568.10%.

The historical rank and industry rank for CollPlant Biotechnologies's Net Margin % or its related term are showing as below:

XTAE:CLGN' s Net Margin % Range Over the Past 10 Years
Min: -9540.79 Med: -303.13 Max: 1.52
Current: -64.05

XTAE:CLGN's Net Margin % is ranked better than
59.59% of 1027 companies
in the Biotechnology industry
Industry Median: -154.15 vs XTAE:CLGN: -64.05

CollPlant Biotechnologies Net Margin % Historical Data

The historical data trend for CollPlant Biotechnologies's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CollPlant Biotechnologies Net Margin % Chart

CollPlant Biotechnologies Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Margin %

Get a 7-Day Free Trial

-481.59

-94.09

1.52

-5,660.05

-64.05

CollPlant Biotechnologies Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Net Margin %	Get a 7-Day Free Trial															-7,594.81	-858.08	56.58	-10,200.00	-1,568.10

Competitive Comparison of CollPlant Biotechnologies's Net Margin %

For the Biotechnology subindustry, CollPlant Biotechnologies's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CollPlant Biotechnologies's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CollPlant Biotechnologies's Net Margin % distribution charts can be found below:

* The bar in red indicates where CollPlant Biotechnologies's Net Margin % falls into.

CollPlant Biotechnologies Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

CollPlant Biotechnologies's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin	=	Net Income (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-25.68	/	40.094
	=	-64.05 %

CollPlant Biotechnologies's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin	=	Net Income (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-17.155	/	1.094
	=	-1,568.10 %

CollPlant Biotechnologies (XTAE:CLGN) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

CollPlant Biotechnologies Net Margin % Related Terms

Thank you for viewing the detailed overview of CollPlant Biotechnologies's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

CollPlant Biotechnologies (XTAE:CLGN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CollPlant Biotechnologies Ltd (XTAE:CLGN) » Definitions » Net Margin %

Comparable Companies

Traded in Other Exchanges

CLGN:USA CPT:Germany

Address

4 Oppenheimer Street, P.O. Box 4132, Weizmann Science Park, Rehovot, ISR, 7670104

Website

https://www.collplant.com

CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The company's revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing.